These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 17070798

  • 1. Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors.
    Brammer MK, Gilmore DL, Matsumoto RR.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):141-5. PubMed ID: 17070798
    [Abstract] [Full Text] [Related]

  • 2. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
    Nguyen EC, McCracken KA, Liu Y, Pouw B, Matsumoto RR.
    Neuropharmacology; 2005 Oct 28; 49(5):638-45. PubMed ID: 15939443
    [Abstract] [Full Text] [Related]

  • 3. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
    Quinteros-Muñoz D, Sáez-Briones P, Díaz-Véliz G, Mora-Gutiérrez S, Rebolledo-Fuentes M, Cassels BK.
    Behav Neurosci; 2010 Oct 28; 124(5):662-76. PubMed ID: 20939666
    [Abstract] [Full Text] [Related]

  • 4. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice.
    Itzhak Y, Ali SF, Achat CN, Anderson KL.
    Psychopharmacology (Berl); 2003 Mar 28; 166(3):241-8. PubMed ID: 12590354
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.
    Fantegrossi WE, Bauzo RM, Manvich DM, Morales JC, Votaw JR, Goodman MM, Howell LL.
    Psychopharmacology (Berl); 2009 Aug 28; 205(2):337-47. PubMed ID: 19421742
    [Abstract] [Full Text] [Related]

  • 8. Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice.
    Matsumoto RR, McCracken KA, Friedman MJ, Pouw B, De Costa BR, Bowen WD.
    Eur J Pharmacol; 2001 May 11; 419(2-3):163-74. PubMed ID: 11426838
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").
    Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS.
    Neuroscience; 2007 May 11; 146(2):509-14. PubMed ID: 17383105
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents.
    Chipana C, Torres I, Camarasa J, Pubill D, Escubedo E.
    Neuropharmacology; 2008 Jun 11; 54(8):1254-63. PubMed ID: 18455739
    [Abstract] [Full Text] [Related]

  • 17. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C, Reither H, Hornykiewicz O.
    Eur J Pharmacol; 2015 May 15; 755():119-26. PubMed ID: 25771452
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
    Kaushal N, Seminerio MJ, Shaikh J, Medina MA, Mesangeau C, Wilson LL, McCurdy CR, Matsumoto RR.
    Neuropharmacology; 2011 May 15; 61(5-6):992-1000. PubMed ID: 21762711
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.